Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Prevention of in-stent restenosis with drug-eluting balloons in patients with postirradiated carotid stenosis accepting percutaneous angioplasty and stenting
- Comparison of drug-coated balloon angioplasty versus standard medical therapy on recurrent stroke and mortality rates among patients with symptomatic intracranial atherosclerotic stenosis: protocol for a systematic review and meta-analysis
- Safety and efficacy of drug coated balloon angioplasty for intracranial atherosclerotic disease
- Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study
- Drug-coated balloons for the treatment of symptomatic intracranial atherosclerosis: initial experience and follow-up outcome
- Neuro Elutax SV drug-eluting balloon versus Wingspan stent system in symptomatic intracranial high-grade stenosis: a single-center experience
- Republished: Endovascular recanalisation with drug coated balloon for chronic symptomatic middle cerebral artery total occlusion
- Endovascular recanalisation with drug coated balloon for chronic symptomatic middle cerebral artery total occlusion
- Off-Label Use of Drugs and Devices in the Neuroendovascular Suite
- Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal Angioplasty: Evidence From the Randomized PACIFIER Trial